Urinary Incontinence

1
Urinary Incontinence

• ACC Conference
• May 30 2007
• John Meier

2
Definition

• Urinary Incontinence is the involuntary loss of
  urine that is objectively demonstrable and a
  social or hygienic problem.
• International Continence Society
• Overactive Bladder is defined as urinary urgency
  with or without urge incontinence usually with
  urinary frequency and nocturia.
• International Continence Society

3
Epidemiology

• Prevalence
• By Sex
• Women
• Young Adult 20-30
• Middle Aged 30-40
• Elderly 50
• Men
• Rates are 1/3 of those of women by age group
  until age 80 at which time rates converge
• By Type
• Women
• 50 Stress
• Then Mixed Stress-Urge
• Least common is Urge but becomes more common as
  woman ages
• Men
• No specific delineation Prostate disease impacts
  assessment

4
Epidemiology

• Additional Facts
• 13 million Americans affected 11 million of whom
  are women
• 1 in 4 women ages 30-59 have experienced an
  episode of urinary incontinence
• 50 or more of the elderly persons living at home
  or in long term-care facilities are incontinent.

5
Epidemiology

• Annual Direct Costs in 1995 Dollars
• estimated as 16.3 billion including 12.4
  billion (76) for women and 3.8 billion (24)
  for men.
• Costs for community-dwelling women (8.6 billion
  69 of costs for women) were greater than for
  institutionalized women (3.8 billion 31).
• Costs for women over 65 years of age were more
  than twice the costs for those under 65 years
  (7.6 and 3.6 billion respectively).
• The largest cost category was routine care (70
  of costs for women) followed by nursing home
  admissions (14) treatment (9) complications
  (6) and diagnosis and evaluations (1).
• Costs were most sensitive to changes in
  incontinence prevalence routine care costs and
  institutionalization rates and costs.

6
Anatomy and Physiology

• Pontine Micturition Center
• Peripheral Micturition Center Bladder Reflex Arc
  of S2-S4
• Filling (150-200 cc) sympathetic reflex--body
  relaxes sphincter tightens detrusor inhibited.
• Further filling(350-500 cc) somatic (voluntary)
  tone increases (external sphincter)
• 5. Voiding detrusor contraction with coordinated
  reflex somatic and
  sympathetic tone
• parasympathetic action (M3 receptors)

7
Risk Factors

• Women childbearing vaginal delivery
  episiotomy estrogen depletion GU surgery
• Men Prostate related pathology
• Both Sexes
• Age
• Changes to Detrusor control overactive
• Decreased Bladder capacity
• Decreased Urinary flow rates
• Decreased Renal Clearance
• Changes in Fluid Balance
• More Medications
• Functional and Cognitive Impairment
• Comorbid Diseases CHF DM Depression CNS
  insults

8
Categories

• Acute - DRIP
• Urge Detrusor Hyperreflexia Detrusor
  Instability
• Stress Weakened Sphincter Function
• Overflow Incomplete Bladder Emptying
• Mixed Urge and Stress
• Functional Physical or Cognitive Impairment
• Rare Extraurethral Fistula Spinal Cord Injury

9
Acute Urinary Incontinence

• DRIP
• Drugs Delirium
• Restricted Mobility Retention
• Infection Impaction (fecal) Inflammation
  (atrophic urethritis vaginitis)
• Polyuric States (CHF DM Hypercalcemia)

10
(No Transcript)
11
Urge

• Definition Involuntary leakage accompanied by or
  immediately preceded by urgency.
• Attributes abrupt urgency with moderate to large
  leakage
• Etiology detrussor over activity (uninhibited
  bladder contractions)
• Sequelae of
• Age
• Interrupted CNS inhibitory pathways
• Bladder irritation
• More common in older adults

12
Stress

• Definition involuntary leakage on effort
  exertion sneeze or coughing.
• Attributes most common cause in young women
  second most common in older women and in men
  after TURP or radical prostatectomy
• Etiology Intra-abdominal pressure exceeds the
  muscular strength of the sphincter
• Impaired urethral support
• Intrinsic sphincter deficiency

13
Overflow

• Definition dribbling and/or continuous leakage
  associated with incomplete bladder emptying due
  to impaired detrussor contractility and/or
  bladder obstruction.
• Attribute typically small volumes elevated
  postvoid residual associated urinary stream
  abnormalities
• Etiology
• Detrusor Under activity 5-10 of elderly
  detrusor muscle changes peripheral neuropathy
  damage to efferents
• Obstruction Men (prostate) Women (s/p
  corrective surgery cystocele)

14
Mixed

• Definition involuntary leakage associated with
  urgency as well as exertion effort sneezing or
  coughing
• Attribute most common cause in women
• Etiology overlap of
• Detrusor over activity
• Impaired urethral sphincter function

15
Work-Up I

• Screening Question
• Do you ever lose control of your urine and wet
  yourself
• Not Are you incontinent

16
Work-Up II

• History
• Specific Symptoms
• Acute/Chronic/Recurrent
• Daily Pattern
• Stress or Urge Pattern
• Precipitants
• Polyuria
• Obstructive Symptoms
• Hesitancy
• Decreased Stream
• Dribbling
• Irritative Symptoms
• Dysuria
• Frequency
• Previous Treatment
• Pelvic Surgery or Radiation
• Medications
• Adrenergic or Cholinergic Modulators
• Narcotics

17
Work-Up III

• Physical Exam
• General Cognitive and Physical function
• Neurologic sacral dermatomes (S2-4)
• Assess UMN vs. LMN
• Rectal sphincter tone impaction prostate
• Pelvic atrophic changes cystocele prolapse
• Palpable Bladder

18
Work-Up IV

• Laboratories (Initial)
• Chemistries
• Urinalysis Glucose (DM) Hematuria (UTI Stones
  etc) Nitrites/LE (UTI)
• Urine Culture
• B12 levels in the elderly

19
Work-Up V

• Diagnostic Testing
• Voiding Diary
• Volumes (day and night) with associated
  symptoms/comments
• Post-void Residual
• Agency for Healthcare Research and Quality
  recommend measurement of PVR in all patients
  presenting with UI
• Cut-off is 100 ml
• If greater than 100 ml evaluate for
  retention/obstruction
• Urodynamic Testing

20
Urodynamic Testing

• Urodynamic tests try to measure nerve and muscle
  function pressures around the bladder flow
  rates and other factors in an attempt to explain
  the urinary incontinence.
• Cystometry catheter placed in the bladder and
  bladder progressively filled to point of 1) urge
  to void is sensed 2) volume at which urge is
  uncontrollable and 3) any involuntary contraction
  is sensed
• Multichannel Cystometrogram in a laboratory
  intra-abdominal pressures are measured with
  rectal or vaginal probe which allows more precise
  measurement of detrusor pressure.
• Uroflowmetry measure urine flow rates.
• Pure Stress Incontinence 91 sensitive 51
  specific
• Pure Urge Incontinence 73 sensitive 55
  specific

21
Urodynamic Testing

• Cochrane Review 2007 Urodynamic investigations
  for management of urinary incontinence in
  children and adults.
• Question does urodynamic testing 1. improve
  clinical outcomes 2. alter clinical decision
  making and 3. is one urodynamic test better and
  addressing points 1 and 2.
• 52 potential studies but only 3 small trials
  involving 184 met the inclusion criteria and only
  two of the three yielded any useful data.
• Findings of 128 women (no men or children) those
  investigated with urodynamic testing were more
  likely to receive active treatment with drugs or
  surgery
• Recognize the need for a large definitive trial
• At the present time there are no clear
  guidelines for the role of urodynamic testing.

22
(No Transcript)
23
(No Transcript)
24
Management

• Treatment is based upon the type of incontinence
  its causes and patient capabilities
• Pelvic Muscle Rehabilitation
• Kegel Exercises younger women 30-80 times per
  day for 8 weeks
• Biofeedback in conjunction with Kegel Exercises
• Vaginal Weight Training 15 min bid 4-6 weeks
• Pelvic Floor Electrical Stimulation in
  conjunction with Kegel Exercises

25
Management

• Behavioral Therapies
• Bladder Training resist the urge and gradually
  expand intervals between voiding
• Toileting Assistance routine and schedule
  voiding
• Surgical Therapies
• Bladder Neck suspension
• Sling Procedure
• Minimally invasive Needle Vaginal Suspension
• Bulking injections

26
Management

• Medications
• Anticholinergics
• Oxybutynin (Ditropan) not recommended for the
  elderly
• Tolterodine (Detrol) most frequently prescribed
  as extended release 4 mg tablet po qday
• OPERA trial and OBJECT trial favor extended
  release oxybutynin for efficacy and tolterodine
  for fewer side effects
• Side Effects dry mouth constipation
  somnolence
• Anti-muscarinic (M3 receptor antagonist)
• Darifenacin (Enablex)
• Solifenacin (Vesicare)
• Side Effects dry mouth and constipation
• Estrogen
• Topical Estrogen 0.5 mg bid for 2 wks then once a
  week
• Estradiol Ring replaced every 90 days
• Estradiol tablet q day for 2 weeks and then one
  tablet q week
• Topical estrogen most likely more effective

27
Management

• Urge
• Behavioral Treatment scheduled voids pelvic MM
• Lifestyle
• Protective Pads
• Bladder MM relaxants (anticholinergics with
  antimuscarinic activity) oxybutynin
  tolteridine trospium solifenacin
• Stress
• Behavioral Treatment
• Estrogen (topical) increase number/responsiveness
  of alpha receptors potentiates alpha agonists
• Alpha-Agonists imipramine (Mixed UI) duloxetine
• Refer pessary surgery (highest cure rates
  slings bladder neck suspension)
• Overflow
• If BPH alpha-1 antagonist (terazosin) 5-alpha
  reductase inhibitor (finesteride)
• Refer further evaluation surgery
• Functional
• Treat underlying infection comorbidity
• Commode urinal living space adaptations

28
Management

• For those that are chronically incontinent
• Scheduled toileting every 2-4 hours
• Prompted Voiding check for dryness and encourage
  toilet use
• Improved access to toilets mobility aides and
  raise level of toilets
• Managing fluids and diet eliminate caffeine
  fluid management and fiber for regular bowel
  movements
• Disposable absorbent garments keep people dry

29
(No Transcript)
30
(No Transcript)
31
Overactive Bladder

• Definition includes urinary urgency with or
  without urge incontinence urinary frequency
  (voiding eight or more times in a 24-hour
  period) and nocturia (awakening two or more
  times at night to void).
• Attributes International Continence Society
  classifies overactive bladder as a syndrome for
  which no precise cause has been identified with
  local abnormalities ruled out by diagnostic
  evaluation
• Etiology disorders of the lower urinary tract
  neurologic conditions behavioral factors such as
  caffeine intake and a variety of commonly
  prescribed drugs
• Ouslander JD Management of Overactive Bladder
  New England Journal of Medicine 2004 350786.

32
Overactive BladderAssociated Conditions

• Urinary Tract Impairment
• Bladder Abnormalities or inflammation
• Impaired Bladder Contractility
• Obstruction
• Urinary Tract Infection
• Women
• Estrogen Deficiency
• Sphincter Weakness
• Men
• Prostate Enlargement

33
Overactive BladderAssociated Conditions

• Neurologic Disorders
• Alzheimers Disease Multi-infarct Dementia
• Cervical or Lumbar Stenosis or Disk herniation
• Diabetic Neuropathy
• Multiple Sclerosis
• Nerve Injury
• Parkinsons Disease
• Spinal Cord Injury
• Stroke

34
Overactive BladderAssociated Conditions

• Systemic Conditions
• Abnormalities of Arginine Vasopressin
• Congestive Heart Failure
• Diabetes
• Sleep Disorders
• Venous Insufficiency
• Functional Behavioral Problems
• Constipation
• Excess intake of Caffeine Alcohol Polydipsia
• Impaired Motility
• Psychologcial Disorders

35
Overactive BladderAssociated Conditions

• Medications
• Anticholinergic Agents
• Calcium Channel Blockers
• Cholinesterase Inhibitors
• Diuretics
• Narcotics

36
(No Transcript)
37
Urinary IncontinencePatient Resources

• http//www.niapublications.org/agepages/urinary.as
  p
• Alliance for Aging Research
• Bladder Health Council c/o American Foundation
  for Urologic Disease
• National Association for Continence
• Simon Foundation for Continence

38
Sources

• Annual Direct Cost of Urinary Incontinence
  Leslie Wilson PhD Jeanette S. Brown MD Grace
  P. Shin PharmD Kim-Oanh Luc PharmD and Leslee
  L. Subak MD Obstetrics Gynecology
  200198398-406
• Incontinence Urinary Comprehensive Review of
  Medical and Surgical Aspects Michael
  OShaungnessy MD eMedicine February 2007.
• Management of Overactive Bladder Joseph G.
  Ouslander M.D. N Engl J Med 2004 3502213 May
  20 2004.
• Overactive Bladder When and How to Treat David
  Mobley MD Neil Baum MD Resident and Staff
  Physician April 2005 9-20.
• Urinary Incontinence Thomas Finucane MD James
  Wright MD Principles of Ambulatory Medicine
  Sixth Edition Lippincott Williams Wilkins
  2003 pp 727-743.
• Urinary Incontinence UpToDate2007.
• Urinary Incontinence in Elderly Women Findings
  From the Health Aging and Body Composition
  Study R A. Jackson MD E Vittinghoff PhD
  Obstetrics Gynecology 2004104301-307
• Urinary Incontinence Guide to Diagnosis and
  Management National Guideline Clearinghouse
  http//www.guideline.gov/